FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Valeant Pharmaceuticals North America Diazepam Rectal Gel Recall

Diazepam Rectal Gel, 2

Valeant Pharmaceuticals North America LLC · Bridgewater, NJ

Risk level
Class III
Reported by FDA
Aug 15, 2018
Recall ID
D-1041-2018
Check your lot numberHow we source this data

Summary

Valeant Pharmaceuticals North America recalled Diazepam Rectal Gel starting Jul 10, 2018. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1041-2018 on Aug 15, 2018. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton. Status: Terminated.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Product description

Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal delivery systems with lubricating jelly and instructions for use per carton, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807; Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215; NDC 68682-650-20.

Lot numbers, UPCs & expiration codes

Lot #: NBBN, Exp 02/22

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1041-2018
Classification
Class III
Status
Terminated
Recall initiated
Jul 10, 2018
FDA report date
Aug 15, 2018
Quantity
306 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Valeant Pharmaceuticals North America LLC

Original FDA data

Every field from FDA enforcement report D-1041-2018, exactly as published.

Show all FDA fields
City
Bridgewater
State
NJ
Status
Terminated
Country
United States
Event ID
80662
Address
400 Somerset Corporate Blvd
Code information
Lot #: NBBN, Exp 02/22
Postal code
08807-2867
Report date
Aug 15, 2018
Product type
Drugs
Recall number
D-1041-2018
Classification
Class III
Recalling firm
Valeant Pharmaceuticals North America LLC
Product quantity
306 cartons
Termination date
Feb 5, 2019
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal delivery systems with lubricating jelly and instructions for use per carton, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807; Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215; NDC 68682-650-20.
Distribution pattern
Nationwide in the USA
Recall initiation date
Jul 10, 2018
Initial firm notification
Letter
Center classification date
Aug 3, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1041-2018, published Aug 15, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls